Astrid Hubert Selected Research

Occludin

7/2014	Effect of tryptophan supplementation on diet-induced non-alcoholic fatty liver disease in mice.
12/2011	Serotonin receptor type 3 antagonists improve obesity-associated fatty liver disease in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Astrid Hubert Research Topics

Disease

9	Spasm (Spasms) 09/2023 - 01/2020
5	Obesity 01/2023 - 12/2011
3	Body Weight (Weight, Body) 01/2023 - 12/2013
3	Fibrosis (Cirrhosis) 10/2022 - 01/2016
3	Neointima 01/2019 - 08/2013
3	Non-alcoholic Fatty Liver Disease 07/2014 - 12/2011
2	Inflammation (Inflammations) 01/2023 - 12/2011
2	Vascular System Injuries 10/2022 - 08/2013
2	Stable Angina 06/2020 - 01/2020
2	Myocardial Infarction 06/2020 - 01/2020
2	Fatty Liver 12/2013 - 12/2011
1	Carotid Artery Injuries 10/2022
1	Coronary Vasospasm (Coronary Artery Vasospasm) 11/2021
1	Hyperplasia 01/2019
1	Cardiomegaly (Heart Hypertrophy) 01/2019
1	Vascular Remodeling 01/2017
1	Hypertrophy 01/2016
1	Heart Failure 01/2016
1	Microvascular Rarefaction 01/2016
1	Hypoxia (Hypoxemia) 01/2016
1	Necrosis 12/2011

Drug/Important Bio-Agent (IBA)

7	Acetylcholine (Acetylcholine Chloride)FDA Link 09/2023 - 01/2020
5	LeptinIBA 01/2023 - 12/2011
4	Leptin ReceptorsIBA 01/2023 - 08/2013
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 07/2014
3	Serotonin (5 Hydroxytryptamine)IBA 07/2014 - 12/2011
2	Adenosine (Adenocard)FDA LinkGeneric 11/2021 - 01/2020
2	Tyrosine (L-Tyrosine)FDA Link 01/2019 - 01/2016
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019 - 08/2013
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2016 - 08/2013
2	Tryptophan (L-Tryptophan)FDA Link 07/2014 - 12/2013
2	OccludinIBA 07/2014 - 12/2011
2	FructoseIBA 07/2014 - 12/2013
2	EndotoxinsIBA 12/2013 - 12/2011
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	Insulin (Novolin)FDA Link 01/2023
1	CollagenIBA 10/2022
1	Recombinases (Recombinase)IBA 10/2022
1	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 10/2022
1	Soluble Guanylyl CyclaseIBA 03/2021
1	riociguatIBA 03/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 02/2021
1	Phenobarbital (Luminal)FDA Link 01/2019
1	Tamoxifen FDA LinkGeneric 01/2019
1	LectinsIBA 01/2019
1	ferric chlorideIBA 01/2019
1	Endothelin-1 (Endothelin 1)IBA 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016
1	Protein Tyrosine PhosphatasesIBA 01/2016
1	LipopolysaccharidesIBA 07/2014
1	Tight Junction ProteinsIBA 07/2014
1	oil red OIBA 07/2014
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2013
1	Triglycerides (Triacylglycerol)IBA 12/2013
1	CarbohydratesIBA 12/2013
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 12/2013
1	Monounsaturated Fatty AcidsIBA 12/2013
1	CaveolinsIBA 08/2013
1	Heparin Lyase (heparin lyase)IBA 08/2013
1	NADPH Oxidases (NAD(P)H oxidase)IBA 08/2013
1	Apolipoproteins E (ApoE)IBA 08/2013
1	LDL Receptors (LDL Receptor)IBA 08/2013
1	RNA (Ribonucleic Acid)IBA 08/2013
1	Palonosetron (Aloxi)FDA Link 12/2011
1	Claudin-1IBA 12/2011
1	Tropisetron (Navoban)IBA 12/2011
1	Serotonin ReceptorsIBA 12/2011

Therapy/Procedure

1	Aftercare (After-Treatment) 08/2013